Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Fertility test is a procedure used to diagnose issues associated with the fertility in female and male. Fertility tests are significant part of fertility treatment and evaluation. By performing this testing, both healthcare professionals and patients can possibly determine what's preventing a couple from achieving pregnancy. The fertility test includes basic sexually transmitted disease testing, sperm analysis, ovulation detection, gynecological exam, ultrasound testing and many others. It also includes follicle stimulating hormone, hysterosalpinogram, laparoscopy, and hysterosalpingo contrast sonogram (HCS) among others.
The United States fertility test market is growing at a rapid pace. Increasing progress in the several end-users such as fertility clinics, hospitals, laboratories and academic and research centers across the country, the massive existence of numerous domestic and international fertility test product manufacturing companies, suppliers, and distributors, ongoing technological advancements and the well-established healthcare industry of the country, high disposable income of the consumers on the health and growing number of cases related to fertility issues across the country are some of the major factors that likely to enhance the growth of fertility test market in the country.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the fertility test market. In addition, complete analysis of changes on fertility test market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on United States economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The pandemic slightly hampered the market growth of the fertility test owing to the lack of supplies and interruption to fertility services.
The study analyses United States fertility test market based on product, mode of purchase, application, and end user.
Various products such as ovulation prediction kits, fertility monitors, and male fertility testing products are covered in the United States fertility test market report. The ovulation prediction kits (OPKs) segment dominated the United States fertility test market in 2020. The increased adoption of ovulation prediction kits across the country during COVID-19 pandemic by couples who want as well as do not want to conceive child is attributed to the growth of the market.
Based on mode of purchase, the market is segmented into direct/prescription-based products, OTC-based products and online products. OTC-based product segment accounted for the largest market share in 2020 and witnessing fastest growth. Moreover, in recent years, several varieties at-home fertility test kits have been made available over-the-counter in the country. These tests offers patients an affordable and convenient means to test their fertility at home. This is in turn increased demand for OTC based products.
The United States fertility test market finds applications in female fertility testing and male fertility testing. The female fertility testing segment dominated the market in 2020 and is expected to maintain its dominance during the estimation period. Increasing number of women across the country between ages 30-34 years and who are expected to conceive child after 30s is the main factors driving the segment growth significantly. For instance, according to World Bank, in the US, in 2019, the female population of the country between ages 30-34 was 6.73 % of total female population.
The end users covered in United States fertility test market are home care settings, hospitals and fertility clinics and other end users. Home care setting segment is anticipated to witness fastest growth in the near future. Surged adoption and demand of at-home fertility test kits by both male and female is likely to contribute to the growth of the segment in the country.
The major key players of market includes Advacare Pharma, Ava, Biozhena, Church & Dwight, Fairhaven Health, Fertility Focus, Hilin Life Products, Medical Electronic Systems, Mira Care, Pregmate, and Tempdrop among others.
The study analyses United States fertility test market based on purchase, application, and end user. Fertility test market by product is segmented into ovulation prediction kits, fertility monitors, and male fertility testing products. The ovulation prediction kits segment is likely to dominate the market over the forecast period. Increased adoption of ovulation prediction kits owing to its several benefits such as low cost is attributed to the market growth. By mode of purchase, the market is segmented into direct/prescription-based products, OTC-based products, and online products. The market finds application in female fertility testing and male fertility testing. The female fertility testing products segment is likely to register fastest growth in years to come owing to the growing adoption of female fertility products owing to its easy availability. By mode of end user, the market is segmented into home care settings, hospitals and fertility clinics and other end users.
Why to buy this report:
